Indivior PLC (NASDAQ:INDV) Short Interest Update

Indivior PLC (NASDAQ:INDV - Get Free Report) saw a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 1,220,000 shares, a drop of 14.1% from the January 31st total of 1,420,000 shares. Approximately 1.1% of the shares of the company are short sold. Based on an average daily trading volume, of 1,230,000 shares, the days-to-cover ratio is currently 1.0 days.

Indivior Stock Down 1.9 %

Shares of NASDAQ INDV traded down $0.19 during trading on Friday, hitting $9.70. The company had a trading volume of 1,135,006 shares, compared to its average volume of 581,794. The stock has a fifty day simple moving average of $10.91 and a two-hundred day simple moving average of $10.60. Indivior has a fifty-two week low of $7.33 and a fifty-two week high of $22.53. The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of -27.71 and a beta of 0.82.

Indivior (NASDAQ:INDV - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.32. The business had revenue of $298.00 million for the quarter, compared to analyst estimates of $262.35 million. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. On average, analysts anticipate that Indivior will post 1.22 earnings per share for the current year.

Remove Ads

Hedge Funds Weigh In On Indivior

Several hedge funds and other institutional investors have recently modified their holdings of the business. GF Fund Management CO. LTD. purchased a new position in shares of Indivior in the fourth quarter worth about $36,000. Public Employees Retirement System of Ohio lifted its stake in shares of Indivior by 32.1% in the fourth quarter. Public Employees Retirement System of Ohio now owns 39,370 shares of the company's stock worth $505,000 after buying an additional 9,576 shares in the last quarter. Two Sigma Investments LP lifted its stake in shares of Indivior by 2.1% in the fourth quarter. Two Sigma Investments LP now owns 110,880 shares of the company's stock worth $1,378,000 after buying an additional 2,237 shares in the last quarter. Stonepine Capital Management LLC lifted its stake in shares of Indivior by 13.0% in the fourth quarter. Stonepine Capital Management LLC now owns 305,000 shares of the company's stock worth $3,791,000 after buying an additional 35,000 shares in the last quarter. Finally, Man Group plc lifted its stake in shares of Indivior by 291.3% in the fourth quarter. Man Group plc now owns 45,365 shares of the company's stock worth $564,000 after buying an additional 33,771 shares in the last quarter. 60.33% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently commented on INDV shares. RODMAN&RENSHAW upgraded shares of Indivior to a "strong-buy" rating in a research report on Tuesday, January 28th. Rodman & Renshaw began coverage on shares of Indivior in a research report on Tuesday, January 28th. They set a "buy" rating and a $16.00 price target on the stock. Finally, Piper Sandler dropped their target price on shares of Indivior from $16.00 to $13.00 and set an "overweight" rating on the stock in a research report on Thursday.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.